skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Does the legal action started have any possibility? Most of these issues end up dying a slow death. Shareholders have been deceived but whether there is sufficient fact here is questionable as is the usual response of the TSX and authorities to simply allow managements actions that are clearly against minority shareholders wishes. It would be nice to see some teeth in investor law.
Read Answer Asked by david on July 08, 2019
Q: I do not understand what is going on at PLI.
I have many shares and want your help to sort out my options.
1. should I participate in the writes any why . Is to late ?
2. what advantage would I get if I owned the writes. Would I be able to guy shares at $ 0.0015 and how does that work.
3. Is there a chance the new management is more capable in running this company which may have solid science but has cheated it's loyal stock holder.
Read Answer Asked by JOSEPH on June 07, 2019
Q: Is Prometic Life Sciences, in your opinion, still a viable company??
I am trying to determine if the current offer of 20 shares for every share owned is worth the small investment required. The shares are currently trading at 035 cents and the offer would provide the additional shares at around a tenth of a cent (if my calculation is correct) This sounds like one of those deals that is too good to be true but I am not 100% convinced. What do you think

Thanks for your thoughts
Read Answer Asked by Bob on June 03, 2019
Q: Do you have anything new to comment on the quarters results?

Prometic reports its 2019 first quarter financial results
CNW Group - Wed May 8, 6:46PM CDT
-- Completion of recapitalization transactions and $75 million in
gross proceeds secured from equity offering
-- New CEO, Board appointees and management structure to
strengthen Corporation's leadership
-- $8.2 million in revenues for Q1-2019 compared to $4.3 million
for Q1-2018
-- Net loss of $28.8 million for Q1-2019 compared to Net loss
$34.6 million for Q1-2018
Read Answer Asked by fwb181 on May 10, 2019
Q: Shareholders of Prometic are being offered a rights issuance where each existing share owned will allow you to buy 20 shares at 1.5 cents. It is trading at 7 cents now real time. Am I missing something or should I jump at the deal. I thought the trading price would instantly come down to the dilution price mentioned in the release.
Read Answer Asked by Steve on April 15, 2019
Q: Prometic is refilling an amendment to the BLA for plasminogen in H2 2019. If approved this orphan drug with fast track designation comes with a priority voucher possibly worth 100 million. Lazard has 2 deals to close in H2 as well which depend on approval. That said they need cash badly and announced an eminent debt restructuring. There at 20 cents today. What's your best guess on what happens to the float and share price after this. Do they have to give the company away at these to raise 100 million when possibly 200 million is coming their way this year.
Read Answer Asked by Steve on April 05, 2019
Q: I have noted your critical comments from time to time about PLI management. We who have held this stock patiently for years and years share your frustration. But I think those who study the amazing product they are trying to licence realize it could well be a game changer for the sick people yearning for a cure. Anyone who buys into the drug field knows the process is long and tedious but if successful the prize is huge. So I am not sure it is fair to blame management for the delays; I think the system is what it is and we who believe in the product must sit and wait. I would appreciate your thoughts on my observations.
Thank you, Peter
Read Answer Asked by Peter on November 08, 2018